Wierenga Wendall
- SEC CIK
- 0001235945
No open-market purchases or sales filed in the past year.
Current role at each company
- CYTK Cytokinetics IncDirectoras of Jul 16, 2025
- CRNX Crinetics Pharmaceuticals, Inc.Directoras of Jun 13, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Wierenga Wendall as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CYTK Cytokinetics Inc
Director9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2025 (view filing) | Apr 21 | Same day | Wierenga WendallDirector | SSale | −20.0K | $38.46 | −$769.2K | −44.6%24.8K after | 10b5-1 |
| Dec 16, 2024 (view filing) | Dec 16 | Same day | Wierenga WendallDirector | SSale | −742 | $48.61 | −$36.1K | −2.9%24.6K after | 10b5-1 |
| Nov 26, 2024 (view filing) | Nov 25 | 1 day | Wierenga WendallDirector | SSale | −742 | $50.00 | −$37.1K | −2.9%24.6K after | 10b5-1 |
| Oct 31, 2024 (view filing) | Oct 28 | 3 daysLate | Wierenga WendallDirector | SSale | −4.45K | $52.25 | −$232.6K | −15.3%24.6K after | 10b5-1 |
| Dec 27, 2023 (view filing) | Dec 27 | Same day | Wierenga WendallDirector | SSale | −10.0K | $73.60 | −$736.0K | −34.9%18.7K after | 2 lots10b5-1 |
| Aug 21, 2023 (view filing) | Aug 21 | Same day | Wierenga WendallDirector | SSale | −6.02K | $32.02 | −$192.8K | −24.9%18.2K after | 10b5-1 |
| Feb 8, 2023 (view filing) | Feb 6 | 2 days | Wierenga WendallDirector | SSale | −7.00K | $45.00 | −$315.0K | −35.8%12.5K after | |
| Sep 1, 2022 (view filing) | Sep 1 | Same day | Wierenga WendallDirector | SSale | −4.17K | $52.79 | −$219.9K | −25.5%12.2K after | |
| Dec 28, 2021 (view filing) | Dec 27 | 1 day | Wierenga WendallDirector | SSale | −4.17K | $44.37 | −$184.8K | −38.1%6.76K after |